Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 1, 2014, Pages 43-51

  Ouyang, Suidong ^a   Hsuchou, Hung ^a   Kastin, Abba J ^a   Wang, Yuping ^a   Yu, Chuanhui ^a   Pan, Weihong ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

bloodbrain barrier; cerebral microvessels; high fat diet; mass spectrometry; obesity; proteomics

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CARBONATE DEHYDRATASE I; CLATHRIN LIGHT CHAIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; COMPLEMENT COMPONENT C1Q; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE REGULATED PROTEIN 78; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEAT SHOCK PROTEIN 70; ISOCITRATE DEHYDROGENASE; MESSENGER RNA; N ETHYLMALEIMIDE SENSITIVE FACTOR; NEURON SPECIFIC ENOLASE; PEROXIREDOXIN 2; PEROXIREDOXIN 6; PHOSPHOGLYCERATE MUTASE; PROPIONYL COENZYME A CARBOXYLASE; PROTEIN DISULFIDE ISOMERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE COMPLEX; RIBONUCLEOPROTEIN; THIOREDOXIN REDUCTASE; TUBULIN; UBIQUITIN THIOLESTERASE; VIMENTIN; VOLTAGE DEPENDENT ANION CHANNEL 3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; BRAIN CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; DET INDUCED OBESITY; DOWN REGULATION; LIPID COMPOSITION; LIPID DIET; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA PROCESSING; RNA TRANSPORT; UPREGULATION; YOUNG ADULT;

EID: 84891826103     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.166     Document Type: Article

References (40)

1. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
3. Insenser M, Montes-Nieto R, Vilarrasa N, Lecube A, Simó R, Vendrell J et al. A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol 2012; 363: 10-19.
4. Perez-Perez R, Garcia-Santos E, Ortega-Delgado FJ, López JA, Camafeita E, Ricart W et al. Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue. Proteomics 2012; 75: 783-795.
5. Hwang H, Bowen BP, Lefort N, Flynn CR, De Filippis EA, Roberts C et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010; 59: 33-42.
6. Kheterpal I, Ku G, Coleman L, Yu G, Ptitsyn AA, Floyd ZE et al. Proteome of human subcutaneous adipose tissue stromal vascular fraction cells versus mature adipocytes based on DIGE. J Proteome Res 2011; 10: 1519-1527.
7. Hsuchou H, He Y, Kastin AJ, Tu H, Markadakis EN, Rogers RC et al. Obesity induces functional astrocytic leptin receptors in hypothalamus. Brain 2009; 132: 889-902.
8. Pan W, Hsuchou H, He Y, Sakharkar A, Cain C, Yu C et al. Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice. Endocrinology 2008; 149: 2798-2806.
9. Alt C, Duvefelt K, Franzen B, Yang Y, Engelhardt B. Gene and protein expression profiling of the microvascular compartment in experimental autoimmune encephalomyelitis in C57Bl/6 and SJL mice. Brain Pathol 2005; 15: 1-16.
10. Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F et al. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm 2013; 10: 289-296.
11. Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 2011; 117: 333-345.
12. Pan W, Kastin AJ. Mahogany, blood-brain barrier, and fat mass surge in AVY mice. Int J Obes (Lond) 2007; 31: 1030-1032.
13. Yu C, Kastin AJ, Ding Y, Pan W. Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp Neurol 2007; 203: 116-122.
14. Kheterpal I, Kastin AJ, Mollah S, Yu C, Hsuchou H, Pan W. Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring. Peptides 2009; 30: 1276-1281.
15. Pejovic V, Soskic V, Pan W, Kastin AJ. Brain proteome of mice lacking the receptors for tumor necrosis factor alpha. Proteomics 2004; 4: 1461-1464.
16. Zvonic S, Lefevre M, Kilroy G, Floyd ZE, DeLany JP, Kheterpal I et al. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics 2007; 6: 18-28.
17. DeLany JP, Floyd ZE, Zvonic S, Smith A, Gravois A, Reiners E et al. Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by adipogenesis. Mol Cell Proteomics 2005; 4: 731-740.
18. Scherp P, Ku G, Coleman L, Kheterpal I. Gel-based and gel-free proteomic technologies. Methods Mol Biol 2011; 702: 163-190.
19. Pan W, Yu C, Hsuchou H, Kastin AJ. The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors. Cell Physiol Biochem 2010; 25: 623-630.
20. Wang X, Choi JW, Oh TS, Choi DK, Mukherjee R, Liu H et al. Comparative hepatic proteome analysis between lean and obese rats fed a high-fat diet reveals the existence of gender differences. Proteomics 2012; 12: 284-299.
21. Lecube A, Poca MA, Colome N, Bech-Serra JJ, Hernández C, Garćia-Ramírez M et al. Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity. J Neuroendocrinol 2012; 24: 944-952.
22. Ye F, Zhang H, Yang YX, Hu HD, Sze SK, Meng W et al. Comparative proteome analysis of 3T3-L1 adipocyte differentiation using iTRAQ-coupled 2D LC-MS/MS. J Cell Biochem 2011; 112: 3002-3014.
23. Kim J, Choi YS, Lim S, Yea K, Yoon JH, Jun DJ et al. Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics 2010; 10: 394-405.
24. Agarwal S, Uchida Y, Mittapalli RK, Sane R, Terasaki T, Elmquist WF. Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice. Drug Metab Dispos 2012; 40: 1164-1169.
25. Jacob A, Decleves X, Scherrmann JM. Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier. Biol Aujourdhui 2012; 206: 177-183.
26. Calabria AR, Shusta EV. Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery. Drug Discov Today 2006; 11: 792-799.
27. Bondia-Pons I, Boque N, Paternain L, Santamaŕia E, Fernández J, Campión J et al. Liver proteome changes induced by a short-term high-fat sucrose diet in wistar rats. J Nutrigenet.Nutrigenomics 2011; 4: 344-353.
28. Cruz-Topete D, List EO, Okada S, Kelder B, Kopchick JJ. Proteomic changes in the heart of diet-induced pre-diabetic mice. J Proteomics 2011; 74: 716-727.
29. Scornavacca G, Gesuete R, Orsini F, Pastorelli R, Fanelli R, de Simoni MG et al. Proteomic analysis of mouse brain cortex identifies metabolic down-regulation as a general feature of ischemic pre-conditioning. J Neurochem 2012; 122: 1219-1229.
30. Hojlund K, Yi Z, Lefort N, Langlais P, Bowen B, Levin K et al. Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia 2010; 53: 541-551.
31. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS, Lee YS. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004; 340: 99-109.
32. Verstraeten VL, Renes J, Ramaekers FC, Kamps M, Kuijpers HJ, Verheyen F et al. Reorganization of the nuclear lamina and cytoskeleton in adipogenesis. Histochem Cell Biol 2011; 135: 251-261.
33. Sarria AJ, Panini SR, Evans RM. A functional role for vimentin intermediate filaments in the metabolism of lipoprotein-derived cholesterol in human SW-13 cells. J Biol Chem 1992; 267: 19455-19463.
34. Rivera P, Romero-Zerbo Y, Pavon FJ, Serrano A, Ló pez-Ávalos MD, Cifuentes M et al. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions. Eur J Neurosci 2011; 33: 1577-1586.
35. Teichert-Kuliszewska K, Hamilton BS, Roncari DA, Kirkland JL, Gillon WS, Deitel M et al. Increasing vimentin expression associated with differentiation of human and rat preadipocytes. Int J Obes Relat Metab Disord 1996; 20: S108-S113.
36. Mayer MP, Bukau B. Hsp70 chaperone systems: diversity of cellular functions and mechanism of action. Biol Chem 1998; 379: 261-268.
37. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 2002; 295: 1852-1858.
38. McArdle A, Dillmann WH, Mestril R, Faulkner JA, Jackson MJ. Overexpression of HSP70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. FASEB J 2004; 18: 355-357.
39. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteino-pathy and ALS. Nature 2013; 495: 467-473.
40. Oliva K, Barker G, Riley C, Bailey MJ, Permezel M, Rice GE et al. The effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry. J Mol Endocrinol 2012; 48: 139-149.